Introduction The cardiovascular dysfunctions in postmenopausal diabetic women increase
relative to premenopausal women. In this study we evaluated protective effects of selective …

In postmenopausal women, the risk of diabetic cardiovascular disease drastically increases
compared with that of premenopausal women. In the present study we surveyed the effects …

Introduction The beneficial effects of the administration of selective estrogen receptor
modulators (SERMs) and estrogen (E2), alone or in combination with each other, have been …

Abstract Objectives Type 2 diabetes (T2D) is a major risk factor for cardiovascular disorders
(CVD), characterized by pathological diastolic as well as systolic dysfunction, ventricular …

Estrogen is known to influence vascular functions and insulin sensitivity, but the relative
contribution of estrogen receptor (ER) isoforms in postmenopausal diabetes-induced …

Postmenopausal diabetic women represent a specific risk group with a greater incidence of
vascular deficits as compared with age-matched men or non-diabetic women. 17β-estradiol …

Abstract Background Type2 Diabetes (T2D) remains one of the most important causes of
cardiovascular diseases (CVD). Menopause leads to an increase in CVD and metabolic …

Estrogen has an anti-obesity effect and plays an important role in improving cardiometabolic
disorders. Weight loss and reduction in calorie intake impede the development of obesity …

The aim of the present study was to investigate the cardiac biomarker changes in
experimental bilateral ovariectomized (OVX) rats in addition to evaluating the role of …

Estrogen replacement therapy (ERT) is claimed to reduce cardiovascular mortality by about
50% in postmenopausal women. This improvement is caused by favorable changes in lipid …